‘Off target’ metabolic effects of anti-inflammatory drugs used for autoimmune disorders needs better treatment strategy

New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review.